ArticleCancer gene therapy2022

Functional characterization of the PI3K/AKT/MTOR signaling pathway for targeted therapy in B-precursor acute lymphoblastic leukemia.

Patricia K Grüninger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.